SecBot SecBot
6-K ·Filed May 19, 2026

IINNW

Inspira Technologies OXY B.H.N. Ltd
NEUTRAL
Impact 4/10
Horizonweeks Processed6mo ago SEC0001185185-26-001910
Notable filing: 6-K
Actionable Insight • Neutral

The name change to QTREX Quantum and pivot toward quantum connectivity/AME is a narrative rebranding with no attached financial data. Monitor for subsequent filings (contracts, revenue guidance, funding rounds) to assess whether the strategic pivot gains commercial traction. The existing medical device legacy and monetization efforts remain unquantified.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$0.1420
T+0 close · May 19, 2026 · via day close
Latest settled
−15.49%
T+20 · $0.1200
Vs SPY
−16.48%
α at T+20
Next horizon
T+60
due 3mo ago
  1. T+0 · May 19 $0.1420entry
  2. T+1 · 6mo ago −67.61%α −68.65% · $0.0460
  3. T+5 · 6mo ago +83.10%α +80.85% · $0.2600
  4. T+20 · 5mo ago −15.49%α −16.48% · $0.1200
  5. T+60 · due 3mo ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Inspira Technologies Oxy B.H.N. Ltd. (IINN/IINNW) has changed its corporate name to Qtrex Quantum Ltd. and will begin trading under the new ticker symbols QTEX/QTEXW on May 20, 2026, following shareholder approval. The name change reflects a strategic pivot from its legacy medical device focus toward an Additively Manufactured Electronics (AME) platform targeting quantum computing connectivity infrastructure. No financial terms, shareholder rights changes, or operational metrics were disclosed.

Key Facts

  • Shareholders approved name change on May 6, 2026; effective with Israeli Registrar on May 10, 2026.
  • New ticker QTEX (common) and QTEXW (warrants) start trading on Nasdaq on May 20, 2026.
  • Company pivots strategic focus from medical devices to AME platform for quantum connectivity, defense, and aerospace applications.
  • No financial figures, revenue, EPS, or deal values provided in the filing.
  • CUSIP unchanged; no shareholder action required.
  • Company continues to hold medical tech portfolio and is 'actively working to monetize certain parts of the medical business.'
  • Form 20-F for FY2025 filed Mar 26, 2026 shows 35,949,247 ordinary shares outstanding as of Dec 31, 2025.

Financial Impact

No financial terms disclosed; purely administrative name change and ticker symbol update.

Risk Factors

  • No revenue or product milestones disclosed for the new AME/quantum focus -- purely forward-looking statements.
  • Potential liquidity issues given $4M market cap and pivot requiring significant R&D investment.
  • Monetization of legacy medical assets may be dilutive or value-destructive.
  • Warrant overhang (IINNW/QTEXW) adds complexity and potential dilution risk.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001185185-26-001910
Document: iinn6k051926.htm0001185185-26-001910
Document: iinnex99-1.htm0001185185-26-001910
Document: 0001185185-26-001910-index-headers.html0001185185-26-001910
Document: 0001185185-26-001910-index.html0001185185-26-001910
Document: 0001185185-26-001910.txt0001185185-26-001910

Track record

11 reports on IINNW

Performance horizon

2 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +213.25% at T+5 after the May 18, 2026 report. 2 of 5 went positive at some point.

Filters
  1. May 19, 202625w ago 6-K Neutral 4/10 Viewing Entry $0.1420 to $0.1200 ▼ −15.49% −16.48% vs SPY
  2. May 18, 202626w ago 6-K Bullish 6/10 Entry $0.0830 to $0.1310 ▲ +57.83% +56.25% vs SPY
  3. Apr 16, 202630w ago 6-K Bullish 7/10 Entry $0.1100 to $0.0690 ▼ −37.27% −43.09% vs SPY
  4. Apr 16, 202630w ago 6-K Neutral 3/10 Entry $0.1100 to $0.0690 ▼ −37.27% −43.09% vs SPY
  5. Apr 15, 202630w ago 6-K Neutral 3/10 Entry $0.1100 to $0.0690 ▼ −37.27% −43.09% vs SPY
  6. Apr 14, 202630w ago 6-K Neutral 3/10 Entry $0.0720 to $0.0690 ▼ −4.17% −10.46% vs SPY
  7. Apr 13, 202631w ago 6-K Bullish 7/10 Entry $0.0600 to $0.0690 ▲ +15.00% +7.27% vs SPY
  8. Apr 6, 202632w ago 6-K Bullish 8/10 Entry $0.1000 to $0.0680 ▼ −32.00% −40.98% vs SPY
  9. Apr 6, 202632w ago 6-K Bullish 7/10 Entry $0.1000 to $0.0680 ▼ −32.00% −40.98% vs SPY
  10. Mar 31, 202632w ago 6-K Neutral 4/10 Entry $0.0800 to $0.0690 ▼ −13.75% −23.17% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens in 8h 46m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 19, 2026